Filing Details

Accession Number:
0001333277-18-000039
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-31 19:24:00
Reporting Period:
2018-08-29
Accepted Time:
2018-08-31 19:24:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1042074 Cymabay Therapeutics Inc. CBAY Pharmaceutical Preparations (2834) 943103561
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1705745 Daniel Menold C/O Cymabay Therapeutics, Inc.
7999 Gateway Boulevard
Newark CA 94560
Vice President, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-29 5,000 $5.00 5,000 No 4 M Direct
Common Stock Disposition 2018-08-29 5,000 $13.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2018-08-29 5,000 $0.00 5,000 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,459 2024-01-21 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The option vested as to 1/4 of the shares on January 22, 2015 and 1/36 per month thereafter.